BioSpace News Archive

Dr. Henderson’s career includes contributions in toxicology, spanning 30 years of research at Lovelace Biomedical.

Maryland is among an initial 11 state rollout and part of the company’s larger plan to expand access to COVID-19 vaccines at CVS Pharmacy locations across the country

Walgreens selected by Centers for Disease Control and Prevention to administer COVID-19 vaccines in 15 states and jurisdictions under federal program; focusing on high-risk, socially vulnerable populations

To meet the advance challenge for generating a physiologically relevant three-dimensional (3D) retinal organoid, Nanoscope researchers® in collaboration with University of Colorado, and Miami University were recently awarded the top prize from the 3D-ROC challenge by the National Institute of Health (NIH).

UNC Health passed a significant milestone , administering its 100,000th COVID-19 vaccine dose.

- Ensysce Biosciences, a clinical stage biopharmaceutical company with a mission to solve prescription drug abuse, is focused on launching a new class of opioid pain therapeutics

LB Pharmaceuticals Inc, (“LB”) a biotechnology company focused on developing and commercializing novel and improved versions of successful CNS treatments, announced today the administration of the first dose of LB-102 in a Phase 1b clinical trial (Clinical Trials Identifier NCT04588129 ).

Seventh Sense Biosystems, Inc. (7SBio), developers of the world’s first push-button blood collection device, announced today that the company has received CE mark approval from the European Commission for its TAP® II blood collection device.

4Q Revenue of $1.355 billion; 68% reported growth; 65% organic growth 4Q GAAP EPS from continuing operations of $3.38; Adjusted EPS of $3.96 Initiates First Quarter and Full Year 2021 Guidance

Among all skin conditions, acne is one of the most widespread and challenging to treat, and troubling for the patient.